Zhang; Geoff G.
Patent Applications and Registrations
Patent applications and USPTO patent grants for Zhang; Geoff G..The latest application filed is for "methods of treating parkinson's disease".
Company Profile
6.19.28
- Zhang; Geoff G. - Vernon HIlls IL
- Zhang; Geoff G. - Vemon Hills IL US
- Zhang; Geoff G. - Libertyville IL US
Patent Activity
| Patent | Date |
|---|---|
| Methods Of Treating Parkinson's Disease App 20220153765 - Cardinal-David; Benoit ; et al. | 2022-05-19 |
| Salts And Crystalline Forms Of An Apoptosis-inducing Agent App 20200361932 - Catron; Nathaniel ; et al. | 2020-11-19 |
| Salts And Crystalline Forms Of An Apoptosis-inducing Agent App 20200255425 - Kind Code | 2020-08-13 |
| Salts and crystalline forms of an apoptosis-inducing agent Grant 10,730,873 - Catron , et al. | 2020-08-04 |
| Salts And Crystalline Forms Of An Apoptosis-inducing Agent App 20200231593 - Catron; Nathaniel ; et al. | 2020-07-23 |
| Carbidopa Prodrug App 20190375770 - Cardinal-David; Benoit ; et al. | 2019-12-12 |
| Crystal Forms App 20190202812 - Brackemeyer; Paul J. ; et al. | 2019-07-04 |
| Salts And Crystalline Forms Of An Apoptosis-inducing Agent App 20190194196 - Catron; Nathaniel ; et al. | 2019-06-27 |
| Formulations of pyrimidinedione derivative compounds Grant 10,201,542 - Li , et al. Feb | 2019-02-12 |
| Carbidopa and L-dopa prodrugs and methods of use Grant 10,174,061 - Cardinal-David , et al. J | 2019-01-08 |
| Acoustic mixing for auto granulation Grant 9,949,973 - Gao , et al. April 24, 2 | 2018-04-24 |
| Carbidopa and L-Dopa Prodrugs and Methods of use App 20180079762 - Cardinal-David; Benoit ; et al. | 2018-03-22 |
| Salts And Crystalline Forms Of An Apoptosis-inducing Agent App 20180065961 - Catron; Nathaniel ; et al. | 2018-03-08 |
| Salts and crystalline forms of an apoptosis-inducing agent Grant 9,840,502 - Catron , et al. December 12, 2 | 2017-12-12 |
| Atrasentan Mandelate Salts App 20170190692 - Gong; Yuchuan ; et al. | 2017-07-06 |
| Formulations Of Pyrimidinedione Derivative Compounds App 20170181973 - Li; Yanxia ; et al. | 2017-06-29 |
| Atrasentan mandelate salts Grant 9,637,476 - Gong , et al. May 2, 2 | 2017-05-02 |
| Formulations of pyrimidinedione derivative compounds Grant 9,629,841 - Li , et al. April 25, 2 | 2017-04-25 |
| Acoustic Mixing For Auto Granulation App 20170007600 - GAO; Ping X. ; et al. | 2017-01-12 |
| Carbidopa And L-Dopa Prodrugs And Methods Of Use App 20160362431 - CARDINAL-DAVID; Benoit ; et al. | 2016-12-15 |
| Carbidopa and L-dopa prodrugs and methods of use Grant 9,446,059 - Cardinal-David , et al. September 20, 2 | 2016-09-20 |
| Carbidopa and L-Dopa Prodrugs and Methods of Use App 20160106765 - CARDINAL-DAVID; Benoit ; et al. | 2016-04-21 |
| Formulations Of Phenyl Uracil Compounds App 20160106849 - Wu; Huailiang ; et al. | 2016-04-21 |
| Salts And Crystalline Forms Of An Apoptosis-inducing Agent App 20160083384 - Catron; Nathaniel ; et al. | 2016-03-24 |
| Formulations of phenyl uracil compounds Grant 9,248,193 - Wu , et al. February 2, 2 | 2016-02-02 |
| Salts and crystalline forms of 4-(4-{[2-(4-chlorophenyl)-4,4-dimethylcyclohex-1-en-1-yl]methyl piperazin-1-yl)-N-({3-nitro-4-[(tetrahydro-2H-pyran-4-ylmethyl)amino]phen- yl}sulfonyl)-2-(1H-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide Grant 9,238,649 - Catron , et al. January 19, 2 | 2016-01-19 |
| Crystalline lopinavir/surfactant adducts Grant 9,174,944 - Gong , et al. November 3, 2 | 2015-11-03 |
| Crystal Forms App 20150175612 - Brackemeyer; Paul J. ; et al. | 2015-06-25 |
| Atrasentan Mandelate Salts App 20150126574 - Gong; Yuchuan ; et al. | 2015-05-07 |
| Method for evaluating the solubility of a crystalline substance in a polymer Grant 9,004,752 - Zhang , et al. April 14, 2 | 2015-04-14 |
| Atrasentan Mandelate Salts App 20150073031 - Gong; Yuchuan ; et al. | 2015-03-12 |
| Atrasentan mandelate salts Grant 8,962,675 - Gong , et al. February 24, 2 | 2015-02-24 |
| Crystalline forms of kinase inhibitors Grant 8,940,759 - Zhang , et al. January 27, 2 | 2015-01-27 |
| Formulations of Phenyl Uracil Compounds App 20140378490 - Wu; Huailiang ; et al. | 2014-12-25 |
| Crystalline Forms Of Kinase Inhibitors App 20140296284 - Zhang; Geoff G. ; et al. | 2014-10-02 |
| Salts And Crystalline Forms Of An Apoptosis-inducing Agent App 20140213596 - Catron; Nathaniel ; et al. | 2014-07-31 |
| Salts and crystalline forms of an apoptosis-inducing agent Grant 8,722,657 - Catron , et al. May 13, 2 | 2014-05-13 |
| Method For Evaluating The Solubility Of A Crystalline Substance In A Polymer App 20130199313 - Zhang; Geoff G. ; et al. | 2013-08-08 |
| [1,2,4]oxadiazol-3-yl Acid Salts And Crystalline Forms And Their Preparation App 20120214848 - Zhang; Geoff G. ; et al. | 2012-08-23 |
| Salts And Crystalline Forms Of An Apoptosis-inducing Agent App 20120157470 - Catron; Nathaniel ; et al. | 2012-06-21 |
| Method For Evaluating The Solubility Of A Crystalline Substance In A Polymer App 20110261857 - Zhang; Geoff G. ; et al. | 2011-10-27 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 